ArticleClinical journal of gastroenterology2026
Fulminant disseminated carcinomatosis of the bone marrow from pancreatic mucinous carcinoma with predominant signet ring cell morphology.
Article in Clinical journal of gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Disseminated carcinomatosis of the bone marrow (DCBM) is a rare and highly aggressive form of bone metastasis arising from solid tumors, most commonly gastric cancers. DCBM originating from pancreatic cancer is exceedingly rare, with only a few cases reported in the literature. A 62-year-old man presented with back pain, loss of appetite, and weight loss. Laboratory tests revealed anemia and thrombocytopenia. Contrast-enhanced computed tomography revealed a hypovascular mass measuring approximately 10 mm in size in the pancreatic tail. Endoscopic ultrasound-guided fine-needle aspiration confirmed the diagnosis of pancreatic mucinous carcinoma. Laboratory evaluation suggested disseminated intravascular coagulation (DIC). Although no nodular bone metastases were detected on imaging studies, bone marrow biopsy revealed diffuse infiltration by adenocarcinoma predominantly composed of tumor cells with signet ring cell carcinoma morphology, leading to a diagnosis of DCBM from pancreatic mucinous carcinoma. The patient developed a subarachnoid hemorrhage due to severe bleeding tendency, and chemotherapy could not be initiated. The patient died on hospital day 11. To our knowledge, this is the first reported case of DCBM arising from pancreatic mucinous carcinoma with bone marrow metastasis predominantly composed of signet ring cell carcinoma morphology. In patients with pancreatic cancer who present with DIC, particularly mucin-producing tumors such as mucinous carcinoma, the possibility of DCBM should be actively suspected, and early bone marrow aspiration and biopsy should be considered.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.